Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents
Pediatric Allergy and Immunology2015Vol. 26(6), pp. 551–556
Citations Over TimeTop 1% of 2015 papers
Abstract
Data indicate that the efficacy of an add-on omalizumab in patients with moderate-to-severe allergic asthma uncontrolled with recommended inhaled steroid treatment is accompanied by an acceptable safety profile.
Related Papers
- → Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria(2015)193 cited
- → Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature(2012)44 cited
- → Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments(2015)27 cited
- → Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience(2015)13 cited
- → P166 Characteristics of patients receiving omalizumab for chronic urticaria in the UAE(2017)